Hymenochirin-1B [P5K,D9K]
General Information
DCTPep ID DCTPep02303
Peptide Name Hymenochirin-1B [P5K,D9K]
Sequence IKLSKETKKNLKKVLKGAIKGAIAVAKMV
Sequence Length 29
UniProt ID Not available
PubChem CID Not available
Origin
Type Synthetic peptide
Classification
ACP Tumor active peptide Membrane lysis
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
A549 | Lung adenocarcinoma | IC50=1.17±0.23 μM | MTT assay | 96 h | 2 |
HepG2 | Hepatoblastoma | IC50=4.28±0.38 μM | MTT assay | 96 h | 2 |
HCT 116 | Colon carcinoma | IC50=4.93±0.51 μM | MTT assay | 96 h | 2 |
A549 | Lung adenocarcinoma | LC50=1.3 ± 0.2 μM | CellTiter-Glo Luminescent Cell Viability assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: LC50=127 ± 9 μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02303
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C142H263N39O35S1
Absent amino acids CDFHPQRWY
Theoretical pI 10.54
Acidic residues 1
Basic residues 9
Polar residues 5
Molecular weight (Average) 3108.95
Molecular weight (Monoisotopic) 3106.97
Common amino acids K
Net charge 8
Instability index (II) -8.38
Aliphatic index 124.48
Grand average of hydropathicity (GRAVY) 0.076
Half Life
20 hours (mammalian reticulocytes, in vitro).
30 min (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 24185042
Title Anti-tumor activities of the host-defense peptide hymenochirin-1B
Doi 10.1016/j.regpep.2013.10.006
Year 2013
Literature 2
Pubmed ID 30789695
Title Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy
Doi 10.1021/acschembio.9b00046
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_4424